Clinical Trials
28 trialsGENTleMEN
University of Washington
START
Lyell Immunopharma, Inc.
Using Imaging Data and Genomic Data to Predict Metastasis of Breast Cancer After Treatment
Chinese University of Hong Kong
LUTON
Hospices Civils de Lyon
MINDACTRelapse
European Organisation for Research and Treatment of Cancer - EORTC
Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients
University of Nebraska
Metastatic Colorectal Cancer: Treatment Response With Dynamic Contrast MRI
American College of Radiology
PROCC
Wake Forest University Health Sciences
This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.
Repertoire Immune Medicines
Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer
British Columbia Cancer Agency
HER-Seq: A Blood-based Screening Study to Identify Patients With HER2 Mutations for Enrollment Into Clinical Research Studies of Neratinib
Puma Biotechnology, Inc.
Long Term Follow up of Subjects Exposed to Genetically Engineered T Cell Receptors
Adaptimmune
Establishment of a PDT Patient Registry
Concordia Laboratories Inc.
Ultrasound and Other Images of Artery Blockages
National Institutes of Health Clinical Center (CC)
IOUS
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
METHEOS
Spanish Oncology Genito-Urinary Group
CPCT-01
UMC Utrecht
Pharmacokinetics of Systemic Anti-Cancer Therapies in the Cerebrospinal Fluid (CSF) of Patients With Advanced Cancer
Duke University
COG-ANGIO
Centre Francois Baclesse
Neurocognition After Gamma Knife Radiosurgery for Multiple Brian Metastases
CancerCare Manitoba
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
Janssen Diagnostics, LLC
GeneSearchâ„¢ Breast Lymph Node (BLN) Assay Post Approval Study
Janssen Diagnostics, LLC
CTCHNSCC01
Chang Gung Memorial Hospital
Analysis of Tokuhashi Score
State University of New York - Upstate Medical University
An Observational Study of Erbitux® in Patients With Metastatic Colorectal Cancer (mCRC) Refractory to Irinotecan-containing Treatment
Merck KGaA, Darmstadt, Germany
Computer Assisted Volumetric Analysis of CT-Identified Metastatic Pulmonary Or Hepatic Lesions
Lahey Clinic
A Prospective Study of Clinical Outcomes for the Pathwork Tissue of Origin Test
Cedar Associates LLC
Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant Therapy
Sysmex America, Inc.